Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
van Alderwerelt van Rosenburgh, Iris K
7  Ergebnisse:
Personensuche X
?
1

Biochemical and structural basis for differential inhibitor..:

van Alderwerelt van Rosenburgh, Iris K. ; Lu, David M. ; Grant, Michael J....
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
2

Drug Sensitivity and Allele‐specificity of First‐line Osime..:

Starrett, Jacqueline H. ; Guernet, Alexis ; Cuomo, Maria Emanuela...
The FASEB Journal.  34 (2020)  S1 - p. 1-1 , 2020
Link: https://doi.org/10.1096/..
 
?
3

Efficacy of osimertinib in patients with lung cancer positi..:

Grant, Michael J ; Aredo, Jacqueline V ; Starrett, Jacqueline H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493186/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Biochemical and structural basis for differential inhibitor..:

van Alderwerelt van Rosenburgh, Iris K ; Lu, David M ; Grant, Michael J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649653/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

Kinetics of receptor tyrosine kinase activation define ERK ..:

Kiyatkin, Anatoly ; van Alderwerelt van Rosenburgh, Iris K ; Klein, Daryl E.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521189/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
6

Drug sensitivity and allele-specificity of first-line osime..:

Starrett, Jacqueline H ; Guernet, Alexis A ; Cuomo, Maria Emanuela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392201/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
7

Biochemical and structural basis for differential inhibitor..:

Iris K. van Alderwerelt van Rosenburgh ; David M. Lu ; Michael J. Grant...
https://doi.org/10.1038/s41467-022-34398-z.  , 2022
Link: https://doi.org/10.1038/..
 
1-7